
AIGEA Medical is a Medtech startup specializing in Artificial Intelligence for radiology workflows and digital imaging. Their flagship product, DeepMammo, is an award-winning cloud solution designed for the early detection of breast cancer. With a management team boasting over 50 years of combined expertise in the MedTech and Radiology sectors, AIGEA Medical leverages proprietary AI algorithms to enhance diagnostic accuracy, reduce workloads for radiologists, and ultimately save lives. The company has received a patent for DeepMammo, highlighting its innovative approach to improving healthcare outcomes.

AIGEA Medical is a Medtech startup specializing in Artificial Intelligence for radiology workflows and digital imaging. Their flagship product, DeepMammo, is an award-winning cloud solution designed for the early detection of breast cancer. With a management team boasting over 50 years of combined expertise in the MedTech and Radiology sectors, AIGEA Medical leverages proprietary AI algorithms to enhance diagnostic accuracy, reduce workloads for radiologists, and ultimately save lives. The company has received a patent for DeepMammo, highlighting its innovative approach to improving healthcare outcomes.
Location: Pisa, Italy
Flagship product: DeepMammo — cloud AI for early breast cancer detection
Tech focus: Explainable and multimodal AI for mammography workflows
Team size: Approximately 5 employees
Funding stage: Pre-seed
Radiology workflows and early breast cancer detection
MedTech / Health AI
Crunchbase lists a Pre-seed round with IKIGAI as lead investor.